Bayer & Roundup: Business
A federal judge has approved Bayer's $7.25 billion settlement resolving cancer claims linked to Roundup weedkiller. The agreement covers both existing non-Hodgkin lymphoma cases and future claims from users who develop the illness.
Verified dispatches tracked: 2.